ROYAL BANK OF CANADA - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 53 filers reported holding TRINITY BIOTECH PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q4 2020$1,000
-50.0%
389
-62.0%
0.00%
Q3 2020$2,0000.0%1,0250.0%0.00%
Q2 2020$2,000
+100.0%
1,025
+2.5%
0.00%
Q1 2020$1,0000.0%1,0000.0%0.00%
Q4 2019$1,0000.0%1,000
+63.4%
0.00%
Q2 2019$1,000
-50.0%
6120.0%0.00%
Q1 2019$2,000
+100.0%
6120.0%0.00%
Q4 2018$1,000
-50.0%
6120.0%0.00%
Q3 2018$2,000
-33.3%
6120.0%0.00%
Q2 2018$3,0000.0%6120.0%0.00%
Q1 2018$3,0000.0%6120.0%0.00%
Q4 2017$3,0000.0%6120.0%0.00%
Q3 2017$3,000
-25.0%
6120.0%0.00%
Q2 2017$4,0000.0%6120.0%0.00%
Q1 2017$4,0000.0%6120.0%0.00%
Q4 2016$4,000
-63.6%
612
-25.0%
0.00%
Q3 2016$11,000
+22.2%
816
+0.5%
0.00%
Q2 2016$9,0000.0%8120.0%0.00%
Q1 2016$9,000
-35.7%
812
-32.3%
0.00%
Q4 2015$14,000
-33.3%
1,200
-33.3%
0.00%
Q3 2015$21,000
-36.4%
1,8000.0%0.00%
Q2 2015$33,000
-5.7%
1,800
-0.4%
0.00%
Q1 2015$35,000
+9.4%
1,808
-0.2%
0.00%
Q4 2014$32,000
-22.0%
1,811
-21.0%
0.00%
Q3 2014$41,000
-89.5%
2,291
-86.5%
0.00%
Q2 2014$392,000
-46.7%
16,998
-44.0%
0.00%
-100.0%
Q1 2014$736,000
-9.2%
30,378
-5.8%
0.00%0.0%
Q4 2013$811,000
-25.6%
32,251
-35.6%
0.00%0.0%
Q3 2013$1,090,000
+6.8%
50,085
-17.3%
0.00%0.0%
Q2 2013$1,021,00060,5930.00%
Other shareholders
TRINITY BIOTECH PLC shareholders Q3 2017
NameSharesValueWeighting ↓
ACK Asset Management 672,100$14,625,0005.62%
GOLDMAN CAPITAL MANAGEMENT INC 312,000$6,789,0004.48%
Lyon Street Capital, LLC 407,586$8,870,047,0004.37%
GREAT POINT PARTNERS LLC 189,071$4,114,0002.85%
Adirondack Research & Management Inc. 161,507$3,514,0002.02%
Park West Asset Management LLC 483,355$10,518,0001.56%
Benchmark Capital Advisors 56,954$1,239,0000.89%
WOODMONT INVESTMENT COUNSEL LLC 76,607$1,667,0000.61%
SHEPHERD KAPLAN KROCHUK, LLC 156,000$3,394,0000.55%
HEARTLAND ADVISORS INC 1,250,364$27,208,0000.50%
View complete list of TRINITY BIOTECH PLC shareholders